Emprise Bank lessened its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 19.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,020 shares of the company’s stock after selling 972 shares during the quarter. Emprise Bank’s holdings in Procter & Gamble were worth $663,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PG. Main Street Research LLC raised its holdings in Procter & Gamble by 4.8% in the second quarter. Main Street Research LLC now owns 367,144 shares of the company’s stock valued at $60,549,000 after buying an additional 16,921 shares during the period. HighMark Wealth Management LLC lifted its holdings in shares of Procter & Gamble by 45.6% during the 2nd quarter. HighMark Wealth Management LLC now owns 5,108 shares of the company’s stock valued at $842,000 after acquiring an additional 1,600 shares in the last quarter. Wealthstream Advisors Inc. boosted its position in Procter & Gamble by 22.2% during the 2nd quarter. Wealthstream Advisors Inc. now owns 1,734 shares of the company’s stock worth $286,000 after purchasing an additional 315 shares during the period. Braun Stacey Associates Inc. increased its holdings in Procter & Gamble by 0.3% in the 2nd quarter. Braun Stacey Associates Inc. now owns 119,217 shares of the company’s stock valued at $19,662,000 after purchasing an additional 333 shares in the last quarter. Finally, Smith Salley Wealth Management raised its position in Procter & Gamble by 4.6% in the second quarter. Smith Salley Wealth Management now owns 147,587 shares of the company’s stock valued at $24,340,000 after purchasing an additional 6,533 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Buying and Selling at Procter & Gamble
In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the sale, the chief executive officer now owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The disclosure for this sale can be found here. Insiders have sold 375,553 shares of company stock valued at $63,829,141 in the last quarter. Corporate insiders own 0.17% of the company’s stock.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. During the same period last year, the firm posted $1.37 EPS. Procter & Gamble’s quarterly revenue was down .1% compared to the same quarter last year. On average, sell-side analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.35%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio is currently 65.69%.
Wall Street Analyst Weigh In
PG has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft increased their target price on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Barclays decreased their target price on shares of Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. BNP Paribas initiated coverage on shares of Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective on the stock. Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Royal Bank of Canada upped their target price on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research report on Wednesday, July 31st. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $175.79.
Get Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
See Also
- Five stocks we like better than Procter & Gamble
- Stock Dividend Cuts Happen Are You Ready?
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- Buy P&G Now, Before It Sets A New All-Time High
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- Manufacturing Stocks Investing
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.